Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Dec 27, 2024; 16(12): 3754-3763
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3754
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3754
Factor | Observation group (n = 52) | Control group (n = 49) | χ2 | P value |
Gender | 0.013 | 0.909 | ||
Male | 27 (51.92) | 26 (53.06) | ||
Female | 25 (48.08) | 23 (46.94) | ||
Age (years) | 0.058 | 0.809 | ||
≤ 7 | 32 (61.54) | 29 (59.18) | ||
> 7 | 20 (38.46) | 20 (40.82) | ||
BMI (kg/m2) | 0.016 | 0.899 | ||
≤ 16 | 28 (53.85) | 27 (55.10) | ||
> 16 | 24 (46.15) | 22 (44.90) | ||
JSGPM-PBM[10] | 0.050 | 0.997 | ||
A | 16 (30.77) | 15 (30.61) | ||
B | 15 (28.85) | 15 (30.61) | ||
C | 13 (25.00) | 12 (24.49) | ||
D | 8 (15.38) | 7 (14.29) |
- Citation: Wang XQ, Kong CH, Ye M, Diao M. Analysis of the efficacy and safety of endoscopic retrograde cholangiopancreatography for the treatment of pediatric pancreatobiliary diseases. World J Gastrointest Surg 2024; 16(12): 3754-3763
- URL: https://www.wjgnet.com/1948-9366/full/v16/i12/3754.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i12.3754